Ceribell, Inc. (CBLL)
20.20
-0.10
(-0.49%)
USD |
NASDAQ |
Feb 20, 15:36
Ceribell EPS Diluted (Quarterly) : -0.3658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 1.017 |
| AtriCure, Inc. | 0.0366 |
| Edwards Lifesciences Corp. | 0.1568 |
| GE Healthcare Technologies, Inc. | 1.289 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.46M |
| Revenue (Quarterly) | 22.59M |
| Total Expenses (Quarterly) | 36.05M |
| Enterprise Value | 605.84M |
| Gross Profit Margin (Quarterly) | 88.28% |
| Profit Margin (Quarterly) | -59.61% |
| Earnings Yield | -7.17% |
| Normalized Earnings Yield | -7.067 |